No new locally-transmitted COVID-19 cases were reported on Sept 2 across the Chinese mainland, the National Health Commission said on Sept 3.
All tertiary and secondary general hospitals across the country will be capable of nucleic acid testing for the novel coronavirus before the end of the year, according to a plan released to improve testing for the virus and coping with COVID-19.
China will further beef up its capacity of nucleic acid testing of novel coronavirus, according to a newly released work plan.
Four Chinese COVID-19 vaccine candidates have started international phase-3 clinical trials, according to the State Council joint prevention and control mechanism against COVID-19.
NMPA holds meeting in preparation for internal review of vaccine regulatory quality management system
The National Medical Products Administration (NMPA) held a meeting on July 20 to examine the construction of the vaccine regulatory quality management system and plan for the internal review of the system.
The National Medical Products Administration (NMPA) held staff training on the establishment of the vaccine regulatory quality management system on July 1.